These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8244908)

  • 1. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.
    Takahashi M; Aoki A; Mito M; Nikkuni K; Ohtsuka T; Saitoh H; Moriyama Y; Shibata A
    Hematol Pathol; 1993; 7(3):153-8. PubMed ID: 8244908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of CFU-GM to increasing doses of rhGM-CSF in patients with aplastic anemia.
    Bacigalupo A; Piaggio G; Figari O; Tong J; Sogno G; Tedone E; Sette A; Ratto MR; Caciagli P; Badolati G
    Exp Hematol; 1991 Sep; 19(8):829-32. PubMed ID: 1868897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Kasper C; Zahner J; Sayer HG
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sustained long-term complete remission in an elderly aplastic anemia patient after cessation of combined therapy consisting of granulocyte-colony stimulating factor and erythropoietin].
    Yasuyama M; Kawauchi K; Sugiyama H; Ohkawa S
    Rinsho Ketsueki; 2000 Jan; 41(1):42-7. PubMed ID: 10695398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies].
    Miyairi Y; Murai K; Utsugisawa T; Narigasawa Y; Ito S; Shimosegawa K; Sugawara T; Numaoka H; Ono Y; Ito T; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1996 Jan; 37(1):22-8. PubMed ID: 8683863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
    Pene R; Appelbaum FR; Fisher L; Lilleby K; Nemunaitis J; Storb R; Buckner CD
    Bone Marrow Transplant; 1993 Mar; 11(3):219-22. PubMed ID: 8467286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rhGM-CSF-EPO hybrid protein MEN 11300 induces anti-EPO antibodies and severe anaemia in rhesus monkeys.
    Coscarella A; Liddi R; Di Loreto M; Bach S; Faiella A; van der Meide PH; Mele A; De Santis R
    Cytokine; 1998 Dec; 10(12):964-9. PubMed ID: 10049520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined GM-CSF and erythropoietin therapy in myelodysplastic syndrome].
    Egli F; Hofer S; Greminger P; Rhyner K
    Schweiz Med Wochenschr; 1989 Dec; 119(49):1777-80. PubMed ID: 2694367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two patients with aplastic anemia successfully treated with G-CSF and erythropoietin].
    Hanamura A; Ichikawa A; Utsumi M; Hotta T
    Rinsho Ketsueki; 1995 Dec; 36(12):1347-52. PubMed ID: 8587170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia.
    Chap L; Schiller G; Nimer SD
    Bone Marrow Transplant; 1993 Aug; 12(2):173-5. PubMed ID: 8401368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.